Decrypting MHC class I trafficking in cross-presentation
Decrypting MHC class I trafficking in cross-presentation
批准号:
530005650
负责人:
Professor Dr. Sebastian Springer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cross-presentation of antigens internalized by dendritic cells (DCs) is critical for priming of CD8+ T cell responses to pathogens and tumors, and for immune tolerance. Despite many published studies, the trafficking pathways and loading compartments for cross-presentation by MHC-I molecules remain unclear. Preliminary evidence suggests that cross-presentation may employ diverse MHC-I sources and trafficking pathways, including newly synthesized MHC-I molecules routed through conventional and non-conventional secretory and/or Golgi-to-endosome pathways, but also MHC-I stores in different subtypes of endosomes, and recycling MHC-I molecules, depending on the antigen entry route and the cell type investigated. This project will bring together two teams with documented strong expertise in studying trafficking of MHC-I molecules. The teams will employ their complementary expertise together with an array of cross-presentation assays to decipher the origin, loading compartments, and travel to the cell surface of MHC-I molecules loaded with cross-presented peptides derived from two antigens (ovalbumin and insulin) internalized by distinct mechanisms (phagocytoseis, mannose receptor endocytosis, Fc receptor endocytosis, pinocytosis). The development of novel assays using the RUSH (retention using selective hooks) and SpyTag/SpyCatcher systems will enable the teams to study synchronized intracellular trafficking as well as internalization of covalently labeled cell surface MHC-I molecules. If possible, the impact of key trafficking pathways will be assessed using conditional deletion models in the context of antitumor vaccination in vivo. Ultimately, the results obtained might be instrumental for pharmacological manipulation of cross-presentation with the objective to up-regulate antitumor immune responses or target antigens into specific processing pathways but also to down-regulate cross-presentation of self- antigens and consequently autoimmune inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecules to manipulate peptide binding to MHC class I molecules, an optimized method for the generation of MHC tetramers by peptide exchange
-
批准号:310813447
-
项目类别:Research Grants (Transfer Project)
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Molecular cell biology of MHC class I retention by the gp40 protein of the murine cytomegalovirus
-
批准号:287481932
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
The intracellular quality control mechanism of major histocompatibility complex class I molecules studied by controlled peptide delivery to cells - a combined cell biological, biochemical, and biophysical investigation
-
批准号:200883174
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Endocytic sorting of MHC class I molecules
-
批准号:190867601
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Enhancement of peptide binding to MHC class I molecules by small compounds - a combined biochemical and computational investigation
-
批准号:161303304
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
The Regulated Intracellular Trafficking and Function of the Chaperones of the MHC Class I Peptide Loading Complex
-
批准号:5419741
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Cell surface clusters of MHC class I molecules: origin, structure, and functions
-
批准号:447012451
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
The causes of MHC-I-opathies in cellular stress
-
批准号:460154834
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MHC-I/CD14介导CD8+T细胞免疫抑制促进去势抵抗前列腺癌免疫逃逸的研究
-
批准号:2026JJ50277
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟上伟
-
依托单位:
去泛素化酶USP9X调控抗原呈递分子MHC-I的机制研究
-
批准号:JCZRQNB202600282
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
西黄丸通过m6A修饰介导YTHDF2/FAM13A/STUB1轴调控PCSK9-MHC-I信号逆转乳腺癌免疫逃逸的机制研究
-
批准号:2026JJ30083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢小兵
-
依托单位:
BCAT2调控氨基酸代谢重编程抑制MHC-I类分子组蛋白乙酰化修饰协助免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡智勇
-
依托单位:
雷公藤衍生物LLDT-8通过调控NLRC5/MHC-I信号通路治疗多发性肌炎的机制研究
-
批准号:JCZRYB202500090
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
MHC-E限制性CD8+调节性T细胞抑制抗肿
瘤免疫反应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:王蕾
-
依托单位:
前纤维蛋白1促进MHC-I自噬性降解导致非小细胞肺癌免疫治疗耐药的机制研究
-
批准号:2025JJ50555
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:卢义晨
-
依托单位:
短程放疗通过IFN-β-CXCR3/MHC-II轴协同直肠癌化疗免疫治疗的分子机制研究
-
批准号:JCZRLH202500227
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于ILF3-DNMT1-MHC-I途径诱导免疫逃逸探讨骨肉瘤免疫检查点抑制剂治疗原发耐药的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹华
-
依托单位:
肿瘤相关成纤维细胞通过CNOT4/MHC-I通
路介导胰腺癌免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:练国达
-
依托单位: